Facebook
Twitter
LinkedIn
Forward
Emerging Diagnostic and Therapeutic Options for Meningioma
Over the past five years, multiple advances in diagnostic imaging, molecular stratification, and neurosurgical and radiotherapeutic approaches have changed the multi-disciplinary management of meningioma, the most common intracranial tumor. This activity will increase learners' awareness of the optimal management of meningioma as well as help them provide better quality of care for their patients with more aggressive types of meningioma. Over the last several years there has been newer data on the use of novel PET imaging, molecular stratification and clinical trials in the space of WHO Grade II and Grade III meningiomas, along with clinical considerations of incorporating novel techniques of radiosurgery versus fractionated radiotherapy and technical considerations of incorporating novel techniques of radiosurgery, proton therapy and radiopharmaceutical therapy. This activity highlights these emerging trends with a diverse panel of multidisciplinary speakers.
Topics:
- Molecular Stratification of Meningiomas
David R. Raleigh, MD, PhD - DOTATATE PET Imaging of Meningiomas
Jana Ivanidze, MD, PhD - Neurosurgical Approach to Meningiomas and Incorporation of Molecular Stratification
Gelareh Zadeh, MD, PhD, FRCS(C) - Radiation for High-Risk Meningiomas & Radiotherapeutic Approaches to Meningioma and Discussion of NRG Trials, Past, Present and Future
Joshua David Palmer, MD - Q and A
Sabin B. Motwani, MD - Moderator
Full Panel
This activity is available from February 25, 2025, through 11:59 p.m. Eastern time on February 24, 2027.
The content was originally presented and recorded at the 2024 ASTRO Annual Meeting.
Target Audience
The activity is designed to meet the interests of medical oncologists, radiation oncologists, surgeons, physicists, nurses, diagnostic radiologists, radiation therapists, radiation dosimetrists and residents.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Understand the use of DOTATATE PET imaging in meningioma.
- Understand how molecular markers are being incorporated into the management of meningiomas.
- Understand when to use stereotactic radiosurgery versus fractionated radiotherapy for meningiomas and which patients are appropriate to enroll on clinical trials.
- Sabin B. Motwani, MD, is employed by RWJ Barnabas Health.
- David R. Raleigh, MD, PhD, is employed by University of California, San Francisco. Dr. Raleigh receives honoraria from Gamma Tile and Tipping Point.
- Jana Ivanidze, MD, PhD, is employed by Weill Cornell Medical College/NewYork-Presbyterian Hospital. Dr. Ivanidze receives grant/research funding from Novartis Pharmaceuticals, GE Health Care and Curium Pharma.
- Gelareh Zadeh, MD, PhD, FRCS(C), is employed by Toronto Western Hospital - University of Toronto.
- Joshua David Palmer, MD, is employed by The James Cancer Center, The Ohio State University Wexner Medical Center. Dr. Palmer receives honoraria from ICOTEC, Huron Consulting, MORE Health and Depuy Synthes. Dr. Palmer receives grant/research funding Varian Medical Systems, The Ohio State University and Kroger.
The person(s) above served as the developer(s) of this activity. Additionally, the ASTRO Education Committee had control over the content of this activity. All relevant financial relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Available Credit
- 1.00 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Certificate of AttendanceThis activity was designated for 1.00 AMA PRA Category 1 Credit™.
Price
Course Fees:
ASTRO members must log in to the ASTRO website to view and receive the member rate.
- Nonmember: $149
- Member: $99
- Member-in-Training: $49
- Student/Graduate Student/PGY-1 Member: $49
- Postdoctoral Fellow Member: $49
If you are an ASTRO member from a low or lower-middle income country, as identified by the World Bank, you can receive a 50% discount off your corresponding registration for this activity. Please email [email protected] to inquire about the discount.
Policies:
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the activity by the expiration date.
Participants using ASTRO Academy activities to satisfy the requirement of a Continuing Certification (MOC) program should verify the credit number and type and availability dates of any activity before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased activities that do not align with their MOC requirement.
The activity and its materials will only be available on the ASTRO website until February 24, 2027, regardless of purchase date. At the expiration of the activity, participants will no longer have access to the activity or its materials. ASTRO reserves the right to remove an activity before its expiration date.
Required Hardware/software
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.